● Recruiting

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Condition: Advanced Solid Tumors · Advanced Breast Cancer · Sponsor: Ensem Therapeutics

PhasePhase 1/Phase 2

Planned participants233

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

Phase 1/2, open-label study of ETX-636 in participants with advanced solid tumors

This description comes directly from the study's public registry record.

Talk to the study team

Janaki Parameswaran, MD · 1-617-383-4993 · janaki.parameswaran@Ensemtx.com

Melinda Snyder · 1-617-383-4993 · melinda.snyder-ext@Ensemtx.com

Always discuss trial participation with your own doctor first.

Locations (15)

Hoag Memorial Hospital Presbyterian	Newport Beach, California, United States	Recruiting
UCSF Helen Diller Family Comprehensive Cancer Center	San Francisco, California, United States	Recruiting
Yale University, Yale Cancer Center	New Haven, Connecticut, United States	Recruiting
Beth Israel Deaconess Medical Center	Boston, Massachusetts, United States	Recruiting
Dana-Farber Cancer Institute	Boston, Massachusetts, United States	Recruiting
Carolina BioOncology Institute	Huntersville, North Carolina, United States	Recruiting
The University of Texas MD Anderson Cancer Center	Houston, Texas, United States	Recruiting
START	San Antonio, Texas, United States	Recruiting
NEXT	Fairfax, Virginia, United States	Recruiting
Fred Hutchinson Cancer Center	Seattle, Washington, United States	Recruiting
Beijing Luhe Hospital,Capital Medical University	Beijing, China	Recruiting
Fujian Cancer Hospital	Fuzhou, China	Recruiting

+ 3 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06993844